Sector revisions Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX 01:29:50 13/08/2026 am IST			5-day change	1st Jan Change
284.34 ^USD	+0.83%		+9.67%	+43.34%

10/08	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT
10/08	Rothschild & Co Redburn Adjusts PT on Charles River Laboratories International to $318 From $241, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		21
BEONE MEDICINES AG		26
IQVIA HOLDINGS INC.		18
CELLTRION, INC.		24
MEDPACE HOLDINGS, INC.		12
ASCENDIS PHARMA A/S	-	18
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
PHARMARON BEIJING CO., LTD.		11
BIO-TECHNE CORPORATION		11
ABIVAX		6
PRAXIS PRECISION MEDICINES, INC.		19
APOGEE THERAPEUTICS, INC.		12
TEMPUS AI, INC.		14
PROTAGONIST THERAPEUTICS, INC.		13
IONIS PHARMACEUTICALS, INC.		21
KYMERA THERAPEUTICS, INC.		22
QIAGEN N.V.		14
Average		16
Weighted average by Cap.		19